- Home
- ITRM vs ECOR Comparison
ITRM vs ECOR Comparison
Compare ITRM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- ECOR
- Stock Information
- Founded
- ITRM 2015
- ECOR 2005
- Country
- ITRM Ireland
- ECOR United States
- Employees
- ITRM N/A
- ECOR N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ITRM Health Care
- ECOR Health Care
- Exchange
- ITRM Nasdaq
- ECOR Nasdaq
- Market Cap
- ITRM 40.0M
- ECOR 37.1M
- IPO Year
- ITRM 2018
- ECOR 2018
- Fundamental
- Price
- ITRM $0.68
- ECOR $4.74
- Analyst Decision
- ITRM Strong Buy
- ECOR Strong Buy
- Analyst Count
- ITRM 2
- ECOR 2
- Target Price
- ITRM $7.00
- ECOR $25.50
- AVG Volume (30 Days)
- ITRM 749.8K
- ECOR 64.1K
- Earning Date
- ITRM 11-13-2025
- ECOR 11-12-2025
- Dividend Yield
- ITRM N/A
- ECOR N/A
- EPS Growth
- ITRM N/A
- ECOR N/A
- EPS
- ITRM N/A
- ECOR N/A
- Revenue
- ITRM N/A
- ECOR $27,700,000.00
- Revenue This Year
- ITRM N/A
- ECOR $24.48
- Revenue Next Year
- ITRM $249.35
- ECOR $44.35
- P/E Ratio
- ITRM N/A
- ECOR N/A
- Revenue Growth
- ITRM N/A
- ECOR 30.16
- 52 Week Low
- ITRM $0.61
- ECOR $4.16
- 52 Week High
- ITRM $3.02
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- ITRM 43.17
- ECOR 39.22
- Support Level
- ITRM $0.61
- ECOR $4.74
- Resistance Level
- ITRM $0.76
- ECOR $5.25
- Average True Range (ATR)
- ITRM 0.05
- ECOR 0.28
- MACD
- ITRM 0.01
- ECOR 0.00
- Stochastic Oscillator
- ITRM 49.65
- ECOR 2.94
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.